After adjustment for other factors, a CFS of 3 or higher and relapsed/refractory disease were the only independent predictors of early zanubrutinib discontinuation. The Clinical Frailty Scale (CFS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results